Close Menu

Applying whole-genome sequencing to populations in the UK's National Health Service (NHS) enabled the genetic diagnosis of rare diseases in thousands of patients, while providing information on the etiological variants and causative genes for many of the disorders, according to a paper appearing in Nature this week. In the study, a University of Cambridge-led team generated WGS data for 13,037 individuals enrolled in 57 NHS hospitals in the UK and 26 hospitals in other countries.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.